All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Chugai Pharmaceutical Co., Ltd. revenue reports

Chugai Pharmaceutical Co., Ltd. financial reports, Chugai Pharmaceutical Co., Ltd. annual revenue in 2020. When does Chugai Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets

Chugai Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in Euro today

Net revenue of Chugai Pharmaceutical Co., Ltd. on 31/12/2019 amounted to 177 333 000 000 €. The dynamics of Chugai Pharmaceutical Co., Ltd. net revenue decreased by -11 233 000 000 € from the last reporting period. Net income, revenue and dynamics - the main financial indicators of Chugai Pharmaceutical Co., Ltd.. Chugai Pharmaceutical Co., Ltd. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Chugai Pharmaceutical Co., Ltd. net income is shown in blue on the graph. A graph of the value of all Chugai Pharmaceutical Co., Ltd. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 157 733 802 174 € - 35 725 883 870 € -
30/09/2019 167 725 308 548 € - 42 820 360 398 € -
30/06/2019 147 650 679 566 € - 30 441 495 072 € -
31/03/2019 137 235 781 664 € - 31 159 303 818 € -
Show:
to

Chugai Pharmaceutical Co., Ltd. financial report charts

The latest dates of Chugai Pharmaceutical Co., Ltd. financial statements available online: 31/03/2019, 30/09/2019, 31/12/2019. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Chugai Pharmaceutical Co., Ltd. is 31/12/2019. Gross profit Chugai Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Chugai Pharmaceutical Co., Ltd. is 113 263 000 000 €

Chugai Pharmaceutical Co., Ltd. quarterly report dates

Cost of revenue Chugai Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Chugai Pharmaceutical Co., Ltd. is 64 070 000 000 € Total revenue Chugai Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Chugai Pharmaceutical Co., Ltd. is 177 333 000 000 € Operating income Chugai Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Chugai Pharmaceutical Co., Ltd. is 49 719 000 000 €

Net income Chugai Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Chugai Pharmaceutical Co., Ltd. is 40 165 000 000 € Current assets Chugai Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Chugai Pharmaceutical Co., Ltd. is 699 680 000 000 € Total assets Chugai Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Chugai Pharmaceutical Co., Ltd. is 1 058 915 000 000 €

  31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
100 744 946 714 € 101 886 146 988 € 90 660 045 150 € 80 391 021 640 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
56 988 855 460 € 65 839 161 560 € 56 990 634 416 € 56 844 760 024 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
157 733 802 174 € 167 725 308 548 € 147 650 679 566 € 137 235 781 664 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
44 223 956 682 € 58 550 778 828 € 43 547 953 402 € 40 999 598 932 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
35 725 883 870 € 42 820 360 398 € 30 441 495 072 € 31 159 303 818 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
27 601 391 818 € 22 316 113 542 € 23 733 941 474 € 22 360 587 442 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
113 509 845 492 € 109 174 529 720 € 104 102 726 164 € 96 236 182 732 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
622 349 967 040 € 594 205 993 642 € 564 147 863 588 € 532 698 589 942 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
941 881 596 370 € 912 013 814 608 € 877 576 784 360 € 829 208 749 676 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
181 401 032 798 € 157 457 174 516 € 132 678 985 870 € 111 912 343 004 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
159 454 942 104 € 158 568 132 538 € 141 950 015 064 € 121 434 204 994 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
182 280 726 540 € 188 747 231 600 € 172 963 444 490 € 152 792 751 884 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
19.35 % 20.70 % 19.71 % 18.43 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
759 600 869 830 € 723 266 583 008 € 704 613 339 870 € 676 415 997 792 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
69 920 086 624 € 55 803 181 286 € 28 691 002 368 € 29 388 353 120 €

Last revenue report of Chugai Pharmaceutical Co., Ltd. was 31/12/2019. According to last financial report total revenue in Chugai Pharmaceutical Co., Ltd. was 157 733 802 174 Euro and changed by 0% since last year. Net income in Chugai Pharmaceutical Co., Ltd. was 35 725 883 870 € in last quartal, net income changes to 0%.

Current cash Chugai Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Chugai Pharmaceutical Co., Ltd. is 203 941 000 000 € Current debt Chugai Pharmaceutical Co., Ltd. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Chugai Pharmaceutical Co., Ltd. is 179 268 000 000 € Total debt Chugai Pharmaceutical Co., Ltd. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Chugai Pharmaceutical Co., Ltd. is 204 930 000 000 €

Chugai Pharmaceutical Co., Ltd. stocks data

Chugai Pharmaceutical Co., Ltd. financials